3rd Quarter - Termination Amendment

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for TETHYS BIOSCIENCE

Period 3rd Quarter 2012 Filed Dec 31, 2012 Signed by Domenic Ruscio, Partner

Official filing
Firm
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Client
TETHYS BIOSCIENCE
Income
$10,000
Expenses
—
Terminated
Jul 31, 2012

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Termination Aug 24, 2012 $10,000 Replaced
3rd Quarter - Termination Amendment (this page) Dec 31, 2012 $10,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to health care policy and the prevention of diabetes. P.L. 111-148-/P.L. 111-152, Affordable Care Act Regulation and reimbursement of laboratory developed tests.

LobbyistCovered position, as disclosed
NICHOLAS G CAVAROCCHI —
JENNIFER RACHEL LEIB Policy Fellow, NIH/NHGRI Office of the Director
KATHRYN SCHUBERT Legislative Director, Rep. Wayne T. Gilchrest

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Regulation and reimbursement of laboratory developed tests.

LobbyistCovered position, as disclosed
NICHOLAS G CAVAROCCHI —
JENNIFER RACHEL LEIB Policy Fellow, NIH/NHGRI Office of the Director
KATHRYN SCHUBERT Legislative Director, Rep. Wayne T. Gilchrest

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.